Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Osphena® (ospemifene) – New indication
January 29, 2019 - Duchesnay announced the FDA approval of Osphena (ospemifene), for the treatment of moderate to severe vaginal dryness, a symptom of vulvar and vaginal atrophy (VVA), due to menopause.
